Equities

HitGen Inc

688222:SHH

HitGen Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)8.50
  • Today's Change-0.150 / -1.73%
  • Shares traded2.86m
  • 1 Year change-42.61%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments954886975
Total Receivables, Net174192154
Total Inventory282525
Prepaid expenses192625
Other current assets, total5.411513
Total current assets1,1811,1451,191
Property, plant & equipment, net322319314
Goodwill, net596679
Intangibles, net675262
Long term investments573113
Note receivable - long term------
Other long term assets------
Total assets1,7301,6691,714
LIABILITIES
Accounts payable111211
Accrued expenses108.676.19
Notes payable/short-term debt06.6943
Current portion long-term debt/capital leases141512
Other current liabilities, total503255
Total current liabilities8674127
Total long term debt219226223
Total debt233247278
Deferred income tax161212
Minority interest2525--
Other liabilities, total263035
Total liabilities371366398
SHAREHOLDERS EQUITY
Common stock401401401
Additional paid-in capital759757752
Retained earnings (accumulated deficit)213173167
Treasury stock - common(20)(20)--
Unrealized gain (loss)------
Other equity, total5.07(7.86)(4.27)
Total equity1,3581,3031,316
Total liabilities & shareholders' equity1,7301,6691,714
Total common shares outstanding399399401
Treasury shares - common primary issue1.241.240
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.